Vermillion Wealth Management, Inc. Bristol Myers Squibb CO Transaction History
Vermillion Wealth Management, Inc.
- $209 Billion
- Q2 2025
A detailed history of Vermillion Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 686 shares of BMY stock, worth $31,933. This represents 0.02% of its overall portfolio holdings.
Number of Shares
686
Previous 1,091
37.12%
Holding current value
$31,933
Previous $66.5 Million
52.28%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...